Correlation Between Kymera Therapeutics and Day One
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Kymera Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Day One.
Diversification Opportunities for Kymera Therapeutics and Day One
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kymera and Day is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Day One go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Day One
Given the investment horizon of 90 days Kymera Therapeutics is expected to under-perform the Day One. In addition to that, Kymera Therapeutics is 1.08 times more volatile than Day One Biopharmaceuticals. It trades about -0.14 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.1 per unit of volatility. If you would invest 1,433 in Day One Biopharmaceuticals on August 24, 2024 and sell it today you would lose (99.00) from holding Day One Biopharmaceuticals or give up 6.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Kymera Therapeutics vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Kymera Therapeutics |
| Day One Biopharmaceu |
Kymera Therapeutics and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Day One
The main advantage of trading using opposite Kymera Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Day One vs. Lyra Therapeutics | Day One vs. Hookipa Pharma | Day One vs. Cingulate Warrants | Day One vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |